Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?

Chronic liver diseases (CLDs) are a public health problem, even if frequently they are underdiagnosed. Hepatic steatosis (HS), encountered not only in nonalcoholic fatty liver disease (NAFLD) but also in chronic viral hepatitis, alcoholic liver disease, etc., plays an important role in fibrosis prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirli, Roxana, Sporea, Ioan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018863/
https://www.ncbi.nlm.nih.gov/pubmed/33834008
http://dx.doi.org/10.1155/2021/6662760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018863/
https://www.ncbi.nlm.nih.gov/pubmed/33834008
http://dx.doi.org/10.1155/2021/6662760

Ejemplares similares